About this compound
PT-141, also catalogued as bremelanotide, is a cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone and a melanocortin receptor agonist.
Studied in
- Melanocortin receptors
- Central signalling
Compound identity
| Compound | PT-141 |
|---|---|
| CAS number | 189691-06-3 |
| Molecular formula | C50H68N14O10 |
| Molecular weight | 1,025.18 Da |
Specifications
- Purity method: HPLC
- Appearance: Lyophilized powder
- Solubility: Reconstitute per protocol; see Supplies for diluents.
- We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.
Endocrine
PT-141
A melanocortin receptor activator, studied in brain signalling.
What the research targets
Studied at melanocortin receptors in the central nervous system.
Research use only
Supplied to qualified professionals and institutions for laboratory research. Not a drug, supplement or cosmetic, and not for human or veterinary use. We publish no dosing or administration guidance of any kind.
Supply formats
Buy one, or a case of ten.
Single unit
One unit.
10 mgVial
PS-3230947-10-MG
On verified account
Case — 10-pack
10 of the same size, at the 10-pack price.
Case · 10 × 10 mg
10-pack price — 10 × one unit, per vial.
PS-3230947-C10-10-MG
On verified account
One-time verification of professional or institutional affiliation. No payment is taken on this site.
From the research library
All articlesCited summaries of the published work behind PT-141 (Bremelanotide) — what was studied, in which model, and what was measured.